ACT Biotech Acquires Clinical and Early Stage Oncology Portfolio Licenses from Bayer Healthcare 08 May 2008 ACT Biotech acquires an anti-angiogenic receptor tyrosine kinase inhibitor entering Phase II clinical studies for colorectal cancer.
Dalton Pharma Services Licenses Thermo Fisher Scientific Enter Drug Development Agreement 07 May 2008 Dalton will use a proprietary Thermo Fisher manufacturing process to produce nucleic-acid biopolymers for pharmaceutical use.
DiaKine Therapeutics and Kinexum Metabolics to Develop Combination Treatment to Type 1 Diabetes 07 May 2008 DiaKine’s Lisofylline and Kinexum’s INGAP peptide combo therapy is set for Phase 2 clinical trial.
GE Healthcare Signs Global Molecular Diagnostic Agreement to Advance Respiratory Drug Development 06 May 2008 Merck will be granted access to Spin Signal Technology™ to provide high speed, quantitative imaging of the lung using Magnetic Resonance Imaging.
Targacept Announces Designation of Lead Compound in Smoking Cessation Program 06 May 2008 The designation triggers milestone payment of $500,000 from GlaxoSmithKline.
Galapagos and Allergan Enter Drug Discovery Collaboration 06 May 2008 Galapagos' service division, BioFocus DPI, will provide assay development and high-throughput screening services for several Allergan targets.
Caliper LS and DiscoveRx Collaborate to Offer Solutions for Cell-Based GPCR Profiling and Lead Optimization 06 May 2008 The combined offering bundles Caliper LabChip systems with DiscoveRx’s cellular assays, including PathHunter™ B Arrestin and cAMP Hunter™.
Malvern Instruments Presentation Shows Power of Near-infrared Chemical Imaging in Quality by Design 05 May 2008 The presentation highlights, how SyNIRgi NIR-CI system can provide the data and product understanding required for Quality by Design.